Renin-Angiotensin-Aldosterone System

Renin-Angiotensin-Aldosterone System is a critical hormone system that regulates blood pressure, fluid and electrolyte balance, and systemic vascular resistance. It plays a pivotal role in maintaining cardiovascular homeostasis and is activated primarily in response to decreased renal perfusion, low sodium levels, or sympathetic nervous system stimulation.

Components of the Renin-Angiotensin-Aldosterone System

Renin

Renin is an aspartyl protease enzyme secreted by the juxtaglomerular cells of the kidney in response to reduced renal blood flow, decreased sodium delivery to the distal tubule, or β1-adrenergic receptor stimulation. Renin initiates the cascade by cleaving angiotensinogen, a glycoprotein produced by the liver, into angiotensin I.

Angiotensinogen

Angiotensinogen is an alpha-2-globulin synthesized and secreted by the liver into the circulation. It is the precursor molecule that renin acts upon to produce angiotensin I.

Angiotensin I

Angiotensin I is a decapeptide formed by the cleavage of angiotensinogen by renin. It has minimal biological activity and serves primarily as a substrate for angiotensin-converting enzyme (ACE).

Angiotensin-Converting Enzyme (ACE)

ACE is a dipeptidyl carboxypeptidase found mainly on the endothelial cells of the lungs and other vascular beds. It converts angiotensin I into angiotensin II by removing two amino acids from the peptide chain.

Angiotensin II

Angiotensin II is an octapeptide and the primary effector molecule of the system. It has potent vasoconstrictive properties, stimulates aldosterone secretion from the adrenal cortex, promotes sodium retention, and stimulates thirst and antidiuretic hormone (ADH) release. Angiotensin II acts mainly through the angiotensin II type 1 receptor (AT1 receptor).

Aldosterone

Aldosterone is a mineralocorticoid hormone synthesized and secreted by the zona glomerulosa of the adrenal cortex in response to angiotensin II, elevated potassium levels, and adrenocorticotropic hormone (ACTH). It promotes sodium and water reabsorption and potassium excretion in the distal nephron, thereby increasing blood volume and pressure.

Physiological Actions and Effects

Regulation of Blood Pressure

Angiotensin II causes vasoconstriction by acting on vascular smooth muscle cells, increasing systemic vascular resistance, and thus raising arterial blood pressure. This effect is immediate and critical during states of hypovolemia or hypotension.

Sodium and Water Retention

Aldosterone increases the expression of epithelial sodium channels (ENaC) and sodium-potassium ATPase pumps in the distal convoluted tubules and collecting ducts of the kidney. This promotes sodium reabsorption, which is osmotically followed by water retention, expanding plasma volume and contributing to blood pressure elevation.

Stimulation of Thirst and ADH Release

Angiotensin II acts on the hypothalamus to stimulate thirst, encouraging fluid intake, and promotes the release of ADH (vasopressin) from the posterior pituitary. ADH enhances water reabsorption in the collecting ducts, further contributing to volume expansion.

Cardiac and Vascular Remodeling

Chronic activation of angiotensin II can lead to pathological changes such as hypertrophy of cardiac muscle cells and fibrosis in the heart and blood vessels. These contribute to the progression of hypertension and heart failure.

Regulation and Feedback Mechanisms

Negative Feedback by Blood Pressure and Volume

Increased blood pressure and plasma volume decrease renin secretion through baroreceptor-mediated signals and enhanced sodium delivery to the macula densa cells, thus downregulating the system.

Interaction with Sympathetic Nervous System

Sympathetic stimulation via β1-adrenergic receptors on juxtaglomerular cells enhances renin secretion, linking nervous system input to the hormonal regulation of blood pressure.

Role of Natriuretic Peptides

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) counterbalance the renin-angiotensin-aldosterone system by promoting vasodilation, natriuresis, and inhibition of renin and aldosterone secretion.

Clinical Significance

Hypertension

Overactivation of the renin-angiotensin-aldosterone system is a major contributor to essential hypertension, leading to sustained vasoconstriction and volume overload.

Heart Failure

In heart failure, the system is chronically stimulated as a compensatory mechanism for reduced cardiac output, but prolonged activation leads to detrimental cardiac remodeling and worsening function.

Therapeutic Targets

Pharmacological interventions targeting this system include:

• ACE inhibitors (e.g., enalapril, lisinopril), which block conversion of angiotensin I to angiotensin II.
• Angiotensin receptor blockers (ARBs, e.g., losartan), which block AT1 receptors.
• Direct renin inhibitors (e.g., aliskiren), which inhibit renin activity.
• Mineralocorticoid receptor antagonists (e.g., spironolactone, eplerenone), which block aldosterone effects.

These therapies reduce blood pressure, improve heart failure symptoms, and decrease progression of kidney disease.

Summary of the Cascade

1. Decreased renal perfusion or sodium delivery → Renin release from juxtaglomerular cells.
2. Renin cleaves angiotensinogen → Angiotensin I.
3. ACE converts angiotensin I → Angiotensin II.
4. Angiotensin II causes vasoconstriction and stimulates aldosterone secretion.
5. Aldosterone promotes sodium and water retention → Increases blood volume and pressure.
6. Increased blood pressure inhibits further renin release (negative feedback).